Small for Gestational Age Infant
10
2
3
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
10.0%
1 terminated out of 10 trials
66.7%
-19.8% vs benchmark
30%
3 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
Pregnancy Outcomes and Maternal Insulin Sensitivity
"Fetal GRowth AbnorMality DEtection Trial"
Parental Participation on the Neonatal Ward - the neoPARTNER Study
A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants
Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.
Select Nutrient and Gene Variant Analysis in a Targeted Diet and Lifestyle Intervention Reduces Preterm Birth
Genetic Diagnosis and Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature
Zinc Supplementation on Very Low Birth Weight Infant
A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA)
A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA